Endeavor

Are Cancer Patients Responding to the COVID Vaccine?

Moffitt study shows patients with myeloid malignancies do develop antibodies after vaccination

Moffitt Study Shows Benefit to Giving CAR T-cell Therapy to Patients Sooner

Using cell therapy as a second-line treatment provided better outcomes for lymphoma patients compared to standard of care

Does Intensifying Lymphodepletion Impact CAR T-Cell Therapy?

Study investigates increasing duration and dosage of chemotherapy in patients with B-cell malignancies

Mom’s Lung Cancer Journey Inspires a Career in Oncology

Denis Imbody now works in a lab alongside the oncologist who cured his mother

Identifying Enhanced Response to Immunotherapy in Melanoma

New studies show gender and cancer origin can affect how well patients respond to treatment

Can Tumor Mutations Cause Resistance to Cellular Immunotherapy?

Moffitt study shows certain alterations can indicate poor outcomes for lymphoma patients receiving CAR T-cell therapy

An Unbreakable Bond

Sara Leahey met Dr. Patrick Hwu as a pediatric cancer patient. More than a decade later, she works as a researcher in his lab.

Moffitt Researchers Hone Precision Prevention

Jessica Islam and Tiffany Carson are working to tailor approaches that are more effective for diverse populations.

5 Questions on the Impact of National Cancer Institute Designation

Dr. John Cleveland discusses why this distinction is important for our patients